Studies have shown that BCAT1 levels are markedly elevated in the blood and ovarian tumour tissues of ovarian cancer patients and that its overexpression in tumour tissues is closely associated with chemotherapy resistance (93–95). Here, BCAT1 is linked to ovarian neoplasm.